Search - tctmd.com

Displaying 101 - 120 of 128

Sort: Relevancy | Date

ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last

News Conference News ACC 2018

ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last

March 05, 2018

Diabetes Drugs Show Benefit in PAD, but Only Mixed Results in Primary Prevention of CV Events

News Conference News AHA 2017

Diabetes Drugs Show Benefit in PAD, but Only Mixed Results in Primary Prevention of CV Events

Michael O'Riordan

November 17, 2017

Same-Same but Different? Noninferiority Trials Need a Revamp, NEJM Review Argues

News Daily News

Same-Same but Different? Noninferiority Trials Need a Revamp, NEJM Review Argues

October 06, 2017

‘A Healthy Brexit’? How a Split From EU Could Affect UK Health System

News Daily News

‘A Healthy Brexit’? How a Split From EU Could Affect UK Health System

Yael L. Maxwell

October 02, 2017

Absorb in Europe: When, How, and by Whom the Beleaguered BVS Is Being Used After Restrictions

News Features

Absorb in Europe: When, How, and by Whom the Beleaguered BVS Is Being Used After Restrictions

Michael O'Riordan

May 08, 2017

News Daily News

Current NSAID Use Linked to Increased Risk of Heart Failure, Large European Analysis Shows

Michael O'Riordan

September 30, 2016

News Daily News

Were Problems With the Point-of-Care Device Used in ROCKET AF Kept From the FDA? BMJ Says Yes

September 28, 2016

News Daily News

Experimental FAAH Inhibitors Do Not Pose Safety Risk, FDA Concludes

Michael O'Riordan

August 12, 2016

News Daily News

Time for Niacin to Be ‘Relegated to Medical History’ as HPS2-THRIVE Analysis Confirms Drug’s Failings

Michael O'Riordan

July 12, 2016

News Daily News

ROCKET AF Investigators Respond to New Questions About Point-of-Care Warfarin Monitoring Device

July 08, 2016

News Features

Brooding Over Brexit: Cardiologists Voice Uncertainty About Effects on Collaboration, Research Funding

Yael L. Maxwell

June 29, 2016

News Daily News

FDA Tackles Regulatory, Scientific Issues With Point-of-Care Coagulation Monitoring Devices

March 24, 2016

News Daily News

ROCKET AF Investigators: Problems With Warfarin Monitoring Device Did Not Skew Results

February 04, 2016

News Daily News

Path to Top FDA Post Gets a Bit Rockier for Califf

Michael O'Riordan

December 09, 2015

News Industry News

Praxbind® (idarucizumab) approved in European Union for the specific reversal of Pradaxa® (dabigatran etexilate)

November 29, 2015

News Industry News

Sanofi New Drug Application for Lixisenatide Accepted for Review by FDA

September 29, 2015

News Industry News

CHMP grants positive opinion for idarucizumab, the specific reversal agent for dabigatran etexilate (Pradaxa®)

September 25, 2015

News Industry News

Regeneron and Sanofi Announce Phase 3 Results Showing LDL-C Reductions of More Than 60 Percent in Japanese Patients Treated with Praluent® (alirocumab) Injection

July 09, 2015

News Industry News

Portola Pharmaceuticals Announces In Vivo Study Results Demonstrating Andexanet Alfa Significantly Reduced Bleeding and Reversed Anticoagulation Activity of Rivaroxaban While Four-Factor Prothrombin C

June 25, 2015

News Daily News

Data Submitted to FDA in Support of Cardiovascular Devices Often Differ From Those Published in Peer-Reviewed Papers

June 22, 2015

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.